Synonyms: EPI589
Compound class:
Synthetic organic
Comment: EPI-589 is a free-radical scavenger that was proposed to reduce cellular oxidative stress and mitochondrial dysfunction. The reduced form of EPI-589 is a substrate of NAD(P)H quinone oxidoreductases. EPI-589 is blood-brain barrier permeable and orally bioavailable.
|
|
No information available. |
Summary of Clinical Use |
EPI-589 is a clinical candidate for neurodegenerative diseases [1-2]. The FDA designated EPI-589 as an orphan drug for ALS in July 2017. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT02462603 | Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease | Phase 2 Interventional | Edison Pharmaceuticals Inc | ||
NCT02460679 | Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS) | Phase 2 Interventional | PTC Therapeutics |